Peritoneal metastasis prediction model of gastric cancer based on 22 genes and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- FUJIAN MEDICAL UNIV UNION HOSPITAL
- Publication Date
- 2018-01-16
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of gene detection, and in particular relates to a gene model for predicting peritoneal metastasis of gastric cancer and its application. Background technique
[0002] According to the latest statistics, gastric cancer is a malignant tumor with the fourth highest incidence rate and the second highest mortality rate in the world, and the highest mortality rate of gastric cancer in my country is the third highest among malignant tumors. Early gastric cancer has no obvious symptoms, and most patients are in the middle and late stages when they see a doctor, and there is no effective treatment. Peritoneal metastasis is the main way of gastric cancer metastasis. Peritoneal metastasis is found in 10-25% of gastric cancer patients before or during operation, and 30-60% of patients after radical operation still have peritoneal metastasis. Therefore, peritoneal metastasis of gastric cancer is the main cause of death and the bo...